933.1000 0.25 (0.03%)
NSE Aug 08, 2025 15:31 PM
Volume: 68,143
 

933.10
0.03%
BOB Capital Markets Ltd.
4QFY25 consolidated proforma sales were 11.4% above our estimates; EBITDA/APAT was -0.4% and -5.9% below estimates
Institutional Investors have decreased holdings from 27.66% to 18.64% in Jun 2025 qtr
More from Cohance Lifesciences Ltd.
Recommended